AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BETAMETHASONE SODIUM PHOSPHATE
6 registrations across 4 African markets— 5 active
Markets with BETAMETHASONE SODIUM PHOSPHATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PROBETA EYE / EAR / NOSE DROPS Ear/Eye/Nasal Drops, Solution | 🇰🇪Kenya | ATCO Laboratories Limited | active | May 2031 |
| BETNACIN-EEN EYE/EAR/NASAL DROPS Eye Drops | 🇰🇪Kenya | Korlyns Therapeutics Limited | active | Jan 2027 |
| IVYBETASONE_EYE 0.1%W/V DROPS DROPS | 🇲🇼Malawi | — | expired | Jun 2018 |
| Probeta Ophthalmic Solution | 🇹🇿Tanzania | ATCO Laboratories Limited | active | — |
| BETAMETHASONE
SODIUM PHOSPHATE OPHTHALMIC
DROPS | 🇺🇬Uganda | ABACUS PARENTERAL DRUGS LIMITED | active | — |
| BETAMETHASONE
SODIUM PHOSPHATE OPHTHALMIC
DROPS | 🇺🇬Uganda | ABACUS PARENTERAL DRUGS LIMITED | active | — |
BETAMETHASONE SODIUM PHOSPHATE in Africa — Regulatory Overview
BETAMETHASONE SODIUM PHOSPHATE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Uganda, Malawi, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.